(Reuters) - Just over a year ago, the backlog of claims by people who allege they’ve been injured from the COVID-19 vaccine stood at nearly 2,300 – a staggering workload for the tiny government ...
Pfizer sold $37.8 billion of its Covid vaccine last year, a small increase of 3% compared with 2021 as demand for the shots slowed. Sales of Paxlovid, however, surged to $18.9 billion in 2022, which ...
Covid-19 has killed more than 1 million people in the United States since the start of the pandemic, and life expectancy has been cut by nearly 2.5 years since 2020. A very early look at data from ...
The 25 most downloaded Nature Communications articles* on COVID-19 published in 2022 illustrate the collaborative efforts of the international community to combat the ongoing pandemic. These papers ...
The Centers for Disease Control and Prevention (CDC) has estimated that almost 1 out of 4 people in the U.S. still hadn’t been exposed to COVID-19 by the end of 2022 after nearly three years of the ...
As the world enters a new year, many public health and infectious disease experts predict that monitoring for new coronavirus variants will be an increasingly important part of COVID-19 mitigation ...
Covid-19 was the fourth leading cause of death in the United States in 2022, according to provisional data from the US Centers for Disease Control and Prevention. It was the third leading cause of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results